Viagra.
(Image credit: LIU JIN/AFP/Getty Images)

It's blue times for the little blue pill.

Drug companies will get their first shot at introducing generic alternatives to Viagra next week, when drugmaker Pfizer Inc.'s patent-protected monopoly expires Monday. But Viagra's parent company isn't going down without a fight, The Associated Press reports: Pfizer is launching its own generic version of the famed erectile dysfunction pill in order to minimize its losses when other generics hit the market.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Kelly O'Meara Morales

Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.